436 related articles for article (PubMed ID: 9531046)
61. Associations of fibrinogen, factor VII and PAI-1 with baseline findings among 10,500 male participants in a prospective study of myocardial infarction--the PRIME Study. Prospective Epidemiological Study of Myocardial Infarction.
Scarabin PY; Aillaud MF; Amouyel P; Evans A; Luc G; Ferrières J; Arveiler D; Juhan-Vague I
Thromb Haemost; 1998 Nov; 80(5):749-56. PubMed ID: 9843166
[TBL] [Abstract][Full Text] [Related]
62. Tissue plasminogen activator (t-PA) and plasminogen activator inhibitor-I (PAI-I) levels in plasma and peritoneal effluent in patients on CAPD.
Selgas R; Cuesta MV; Riñon C; Romero JR; de Alvaro F; Bajo MA; Sanchez-Sicilia L
Adv Perit Dial; 1992; 8():160-5. PubMed ID: 1361777
[TBL] [Abstract][Full Text] [Related]
63. Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction.
Hamsten A; Wiman B; de Faire U; Blombäck M
N Engl J Med; 1985 Dec; 313(25):1557-63. PubMed ID: 3934538
[TBL] [Abstract][Full Text] [Related]
64. [Fibrinolytic activity and tissue plasminogen activator level in healthy individuals prior to and after a ten-minute venous stasis].
Kubicka A; Libura M; Sacha T; Swadźba J; Undas A; Wandzilak M
Pol Tyg Lek; 1993 Feb 1-8; 48(5-6):116-9. PubMed ID: 8361905
[TBL] [Abstract][Full Text] [Related]
65. Plasminogen activator and plasminogen activator inhibitor activities in men with coronary artery disease.
Oseroff A; Krishnamurti C; Hassett A; Tang D; Alving B
J Lab Clin Med; 1989 Jan; 113(1):88-93. PubMed ID: 2783330
[TBL] [Abstract][Full Text] [Related]
66. Endogenous testosterone, fibrinolysis, and coronary heart disease risk in hyperlipidemic men.
Glueck CJ; Glueck HI; Stroop D; Speirs J; Hamer T; Tracy T
J Lab Clin Med; 1993 Oct; 122(4):412-20. PubMed ID: 8228555
[TBL] [Abstract][Full Text] [Related]
67. Impaired fibrinolysis in obstructive jaundice--evidence from clinical and experimental studies.
Colucci M; Altomare DF; Chetta G; Triggiani R; Cavallo LG; Semeraro N
Thromb Haemost; 1988 Aug; 60(1):25-9. PubMed ID: 3142090
[TBL] [Abstract][Full Text] [Related]
68. Does low protein concentration of tissue-type plasminogen activator predict a low risk of spontaneous deep vein thrombosis?
Gram J; Sidelmann J; Jespersen J
Thromb Haemost; 1995 Aug; 74(2):718-21. PubMed ID: 8585012
[TBL] [Abstract][Full Text] [Related]
69. [Evaluation of the fibrinolytic system in myocardial infarction].
Moreno JA; Cornudella R; Gálvez M; Angós JA; Romero S; Gutiérrez M
Sangre (Barc); 1994 Feb; 39(1):23-7. PubMed ID: 8197514
[TBL] [Abstract][Full Text] [Related]
70. Renal and hepatic handling of endogenous tissue-type plasminogen activator (t-PA) and its inhibitor in man.
Brommer EJ; Derkx FH; Schalekamp MA; Dooijewaard G; vd Klaauw MM
Thromb Haemost; 1988 Jun; 59(3):404-11. PubMed ID: 3142078
[TBL] [Abstract][Full Text] [Related]
71. Effect of isotretinoin on endogenous tissue-type plasminogen activator (t-PA) and plasminogen activator inhibitor 1 (PAI-1) in humans.
Wallnöfer AE; van Griensven JM; Schoemaker HC; Cohen AF; Lambert W; Kluft C; Meijer P; Kooistra T
Thromb Haemost; 1993 Dec; 70(6):1005-8. PubMed ID: 8165591
[TBL] [Abstract][Full Text] [Related]
72. A dynamic test to investigate potential tissue plasminogen activator activity. Comparison of deamino-8-D-argininevasopressin with venous occlusion in normal subjects and patients.
Sultan Y; Harris A; Strauch G; Venot A; De Lauture D
J Lab Clin Med; 1988 Jun; 111(6):645-53. PubMed ID: 3131470
[TBL] [Abstract][Full Text] [Related]
73. Relation of habitual diet and cardiorespiratory fitness to blood coagulation and fibrinolytic factors.
Rankinen T; Rauramaa R; Väisänen S; Penttilä IM; Uusitupa M
Thromb Haemost; 1994 Feb; 71(2):180-3. PubMed ID: 8191395
[TBL] [Abstract][Full Text] [Related]
74. [The fibrinolytic system in patients with dilated myocardiopathy].
Fernández P; Marín F; Marco P; Roldán V; García MC; Martínez JG; Sogorb F; Calatayud R
Sangre (Barc); 1996 Oct; 41(5):351-5. PubMed ID: 9026920
[TBL] [Abstract][Full Text] [Related]
75. Tissue plasminogen activator release in chronic venous hypertension due to heart failure.
Keber I; Keber D; Stegnar M; Vene N
Thromb Haemost; 1992 Sep; 68(3):321-4. PubMed ID: 1440498
[TBL] [Abstract][Full Text] [Related]
76. Physical activity status and adverse age-related differences in coagulation and fibrinolytic factors in women.
DeSouza CA; Jones PP; Seals DR
Arterioscler Thromb Vasc Biol; 1998 Mar; 18(3):362-8. PubMed ID: 9514404
[TBL] [Abstract][Full Text] [Related]
77. Fibrinolytic potential and antiphospholipid antibodies in systemic lupus erythematosus and other connective tissue disorders.
Jurado M; Páramo JA; Gutierrez-Pimentel M; Rocha E
Thromb Haemost; 1992 Nov; 68(5):516-20. PubMed ID: 1455397
[TBL] [Abstract][Full Text] [Related]
78. Fibrinogen, t-PA, and PAI-1 plasma levels in patients with pulmonary hypertension.
Huber K; Beckmann R; Frank H; Kneussl M; Mlczoch J; Binder BR
Am J Respir Crit Care Med; 1994 Oct; 150(4):929-33. PubMed ID: 7921465
[TBL] [Abstract][Full Text] [Related]
79. Evaluation of tissue plasminogen activator and plasminogen activator inhibitor-I levels in acute myocardial infarction.
Yamada S; Yamada R; Ishii A; Ashikawa K; Kawamitsu H; Fujita K
J Cardiol; 1996 Apr; 27(4):171-8. PubMed ID: 8642503
[TBL] [Abstract][Full Text] [Related]
80. Association between heart rate recovery after exercise testing and plasminogen activator inhibitor 1, tissue plasminogen activator, and fibrinogen in apparently healthy men.
Jae SY; Carnethon MR; Ahn ES; Heffernan KS; Choi YH; Lee MK; Fernhall B
Atherosclerosis; 2008 Mar; 197(1):415-9. PubMed ID: 17681507
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
